Whalesbook
Several prominent Indian pharmaceutical manufacturers are currently recalling specific lots of their products in the US market, as reported by the US Food and Drug Administration (USFDA) in its latest Enforcement Report. Glenmark Pharmaceuticals' US subsidiary is recalling 13,824 tubes of Azelaic Acid Gel produced at its Goa plant due to CGMP deviations, identified after market complaints of gritty texture. Granules India is recalling over 49,000 bottles of extended-release capsules for ADHD treatment due to failed impurities and degradation specifications. Sun Pharma is recalling 1,870 kits of a renal imaging agent due to failed dissolution specifications. Zydus Pharmaceuticals (USA) Inc. is recalling 8,784 bottles of the antiviral drug Entecavir tablets because of failed impurity/degradation specifications. Lastly, Unichem Pharmaceuticals USA Inc. is recalling 230 bottles due to a label mix-up.
Impact
This news highlights regulatory compliance challenges faced by Indian drug manufacturers in the US. It can lead to stock price volatility for the affected companies, increased scrutiny from regulators, and potential impacts on future exports. Investor confidence in the Indian pharmaceutical export sector may also be affected.
Rating: 7/10
Definitions:
CGMP: Current Good Manufacturing Practices. These are quality standards that ensure products are consistently produced and controlled according to quality standards appropriate for their intended use and as required by the marketing authorization.
Class II Recall: Initiated when the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health outcomes is remote.
Class III Recall: Initiated in a situation where use of, or exposure to a violative product is not likely to cause adverse health consequences.
Failed impurities/degradation specifications: The product contains impurities or has degraded beyond the acceptable limits set by regulatory authorities, potentially affecting safety or efficacy.
Failed dissolution specifications: The drug product does not dissolve at the rate required for the active ingredient to be absorbed properly by the body.
Label Mix-up: The product is packaged with an incorrect label, which could lead to incorrect dosage or usage instructions.
Azelaic Acid Gel: A topical medication used to treat acne and rosacea.
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, extended-release capsules: Medications commonly prescribed for Attention Deficit Hyperactivity Disorder (ADHD).
Renal imaging agent: A substance used in medical scans to help visualize the kidneys.
Entecavir tablets: An antiviral medication used to treat Hepatitis B infection.